Belgicastraat 9 1930 Zaventem - Belgium

+32 2 588 76 58

Cryolipolysis: Mechanisms and Principles

Cryolipolysis: physics of cold, lipid crystallization, adipocyte apoptosis, clinical results and treatment protocols

Definition

Cryolipolysis is a non-invasive body contouring technique using controlled cold (temperatures 4-10°C) to selectively crystallize and destroy adipocytes (fat cells) in subcutaneous tissue. Fat destruction results from programmed apoptosis triggered by lipid crystallization, followed by macrophage phagocytosis and progressive lymphatic elimination over 8-12 weeks. Unlike liposuction, cryolipolysis preserves skin integrity and adjacent structures (nerves, blood vessels).

Physical Principles and Thermodynamics

Cryolipolysis relies on the distinct thermodynamic properties of adipocytes compared to skin, based on the differential melting point of lipids (18-25°C). Triglycerides and phospholipids composing the adipocyte membrane crystallize at approximately 4°C, a temperature lower than the freezing point of water (0°C) but higher than temperatures needed to destroy nerve or dermal collagen. By cooling to -10°C ± 2°C for 30-60 minutes, cellular lipids progressively crystallize, generating intracellular microcrystals (lipid crystal formation) inducing cellular mechanical stress. Simultaneously, the vascular system vasoconstricts, reducing local perfusion and concentrating the cold effect. Manstein et al. (2008) established that this selective crystallization at temperatures (-10°C to -5°C) causes adipocyte destruction without dermal collagen coagulation or skin necrosis. Hot-cold alternation in certain devices (IceSlim IV) improves results by optimizing post-treatment vasodilation, increasing favorable reactive inflammation for phagocytosis (42°C alternating with -10°C increases efficacy by 15-20%).

Biological Mechanism: Apoptosis and Cellular Elimination

Once crystallized, cellular lipids trigger membrane disruption and activation of the intrinsic apoptotic cascade. Initiated adipocytes undergo:

1

days 1-3

caspase-3 activation, apoptotic DNA fragmentation, formation of apoptotic bodies containing crystallized lipids;

2

weeks 1-2

innate macrophagic infiltration (recruitment of CD68+ inflammatory cells, TNF-α production);

3

weeks 2-8

progressive phagocytosis of apoptotic adipocytes by macrophages (lipophages), intracellular enzymatic digestion;

4

weeks 8-12

lymphatic transport of lipid debris to regional lymph nodes, definitive elimination via lymphatic circulation and systemic metabolism. Kennedy et al.

2015

documented that this process produces final fat volume reduction of 20-30% per zone without detectable hyperlipidemia or systemic complications. Temporal kinetics are critical: initial results visible weeks 2-4 (erythema, inflammatory swelling), definitive results visible week 12 post-treatment (plateau of adipocyte reduction).

Technical Parameters and Protocols

Modern cryolipolysis systems (IceSlim IV) precisely control:

parameter range unit optimal_range impact
Cooling temperature -10°C to +42°C °C -10°C ± 2°C (destructive), +42°C (circulation enhancement) Temperatures >-5°C insufficient; <-15°C risk of skin necrosis. Alternation -10°C/+42°C boosts efficacy 15-20%
Cooling duration 30-60 min min 45-60 min Durations <30 min result in incomplete crystallization. >60 min increases risk of post-treatment paresthesia without additional efficacy gain
Number of simultaneous applicators 1-4 applicators 4 (360° system) Multiple applicators efficiently cover large zones. IceSlim IV: 4 synchronized applicators treat flanks + abdomen in 45 min single session
Vacuum/suction pressure 0.5-1.2 bar bar 0.8-1.0 bar Suction lifts skin toward applicator, maximizing thermal contact. >1.2 bar: risk of excessive ecchymosis. <0.5 bar: reduced efficacy
Applicator surface area 40-90 mm² mm² 70-90 mm² (large applicators) Large surfaces treat significant fat volumes; adaptable for localized areas (chin: 40 mm²)
Number of recommended sessions 1-3 sessions 1-2 per zone 1 session: 20-25% reduction. 2 sessions (12 weeks apart): cumulative reduction 30-35%. 3+ rare, declining marginal efficacy

Clinical Course of a Cryolipolysis Session

  1. Pre-treatment consultation: evaluation of fatty zones, realistic expectations, before photography, informed consent signature documenting paresthesia risks (transient is standard)
  2. Anatomical marking: delineation with marker of zones to be treated, identification of bony reference points for future reproducibility. Palpation identification of target areas
  3. Application of protective gel: hydrogel layer between skin and applicator, prevents adhesion and cold burn. Skin cleansing with alcohol before gel application
  4. Positioning IceSlim IV applicator: placement of 4 synchronized applicators, verification of adequate vacuum (skin lifted 5-8 mm in suction chamber). Patient comfort verification before cooling activation
  5. Initial cooling phase (-10°C, 0-5 min): gradual temperature increase, patient experiences intense but tolerable cold. Comfort monitoring, vacuum adjustment if needed
  6. Main cooling phase (-10°C, 25-55 min): maintenance of stable temperature. Transient paresthesia phase normally observed at min 5-10 (patient reports tingling sensation) disappearing after several minutes via proprioceptive adaptation
  7. Rewarming-alternation phase (+42°C, min 50-60): progressive transition to +42°C over 5-10 min, patient experiences pleasant warmth promoting vasodilation and circulation. 2-3 cycles of hot-cold alternation optimize efficacy
  8. Applicator removal and post-treatment massage: vigorous massage of treated zone 2-3 min post-cryolipolysis accelerates inflammatory reaction and fragmentation of residual fat crystals
  9. Immediate post-session care: application of soothing cream, possibility of moderate edema (normal), recommendations for normal activities possible immediately, no downtime required
  10. Follow-up and control photography: photography week 4 (swelling resorbed), weeks 8-12 (definitive results). Possibility of complementary session 12 weeks later if reduction insufficient

Frequently Asked Questions on Cryolipolysis

No true pain, but significant thermal discomfort during the first 5-10 minutes of intense cold. Paresthesias (tingling) are normal and transient. After 15-20 minutes, sensory adaptation occurs and sensation becomes tolerable. Post-treatment massage relieves residual discomfort.

First results visible weeks 2-4 (inflammatory swelling beginning apoptosis). Optimal results weeks 8-12 post-treatment (complete adipocyte phagocytosis). Results stabilize weeks 12-16. Patience recommended: progressive improvement visible weekly.

1 session produces excellent 20-25% reduction for small/medium zones (chin, flanks). Large zones (complete abdomen): 1-2 sessions recommended. 12-week spacing between sessions maximizes results. 3+ sessions rarely necessary, declining efficacy.

Common (24-48h): mild erythema, swelling, transient paresthesias disappearing weeks 1-4. Rare: paradoxical fat hyperplasia (1-2%, localized fat hypertrophy, potentially reversible with later treatment). Contraindications: cryoglobulinemia, history of cold-induced necrosis.

No: cryolipolysis does not produce excess skin. Progressive fat reduction allows skin to retract progressively (collagen reorganizes via mild inflammatory stimulus). Skin firmness slightly improves post-treatment. Patients with good baseline skin elasticity maintain refined contours.

Costs vary geographically. Typically 600-1200€ per session (1-4 applicators). 360° cryolipolysis (4 simultaneous applicators IceSlim IV): 1200-1500€ per single session compared to 4 traditional sessions (2400-4800€). Alternative EMT, cavitation less expensive but require more sessions.

Sources scientifiques

  1. Manstein D, Laubach H, Watanabe K, et al.. Selective cryolysis: a novel method of non-invasive fat removal. Lasers in Surgery and Medicine (2008) ;40(9) :595-604 . PMID: 18951424
  2. Kennedy JF et al.. Quantification and Characterization of the Thermal Properties of Human Adipose Tissue: A Comparative Study. Aesthetic Surgery Journal (2015) ;35(3) :380-389 . PMID: 25746718
  3. Kilmer SL et al.. Safety and efficacy of cryolipolysis for non-invasive reduction of submental fat. Lasers in Surgery and Medicine (2016) ;48 :3-13 . PMID: 26607045
  4. Suh DH et al.. Cryolipolysis for noninvasive body contouring: a quantitative assessment of efficacy using computed tomography scans. Dermatologic Surgery (2012) ;38(4) :559-567 . PMID: 22353695
  5. Avram MM. Cryolipolysis: a novel approach to the removal of stubborn fat. Journal of Cosmetic Dermatology (2009) ;8(4) :280-285 . PMID: 19925567
  6. Shermak MA. Cryolipolysis and other non-invasive body contouring procedures. Plastic and Reconstructive Surgery (2016) ;137(3) :440e-450e . PMID: 26910672

Vous souhaitez en savoir plus ?

Contactez nos experts pour une démonstration personnalisée des appareils NeoCure.

Demander une démonstration
Ce contenu est fourni à titre informatif et ne remplace pas un avis médical professionnel. Contenu vérifié par l'équipe technique NeoCure — 23/03/2026

Nous contacter

Interested?

Contact us for more information and a demonstration of our device!

Address
Belgicastraat 9
1930 Zaventem
Belgium
Phone

+32 (0)2 588 76 58

More than 2,500 customers trust us. Join them now and expand your business.